The world has already witnessed the cost of underestimating an infectious disease. Pakistan has a chance to act before mpox ...

A collaborative research effort between the A*STAR Infectious Diseases Labs (A*STAR IDL) and the A*STAR Institute of High ...

On August 13, 2024, the Africa Centres for Disease Control and Prevention (Africa CDC) declared the multi-country mpox ...

A study has found that a single dose of the Imvanex vaccine provides protection against Mpox with 84% effectiveness. For people with HIV, however, a single dose of the vaccine fails to offer ...

Kaseya is director general of the Africa Centers for Disease Control and Prevention. He's talking about mpox, a virus that causes painful blisters and can be fatal. For much of the world ...

A study by A*STAR Infectious Diseases Labs (A*STAR IDL) and A*STAR Institute of High Performance Computing (A*STAR IHPC) has assessed the airborne transmission risk of mpox compared to SARS-CoV-2 and ...

The following is a summary of “Safety and effectiveness of MVA-BN vaccination against mpox in at-risk individuals in Germany ...

Press Release - The Director-General of the World Health Organization (WHO) is hereby transmitting the report of the third ...

Pakistan reports its second mpox case of the year with a man in Karachi testing positive. The patient, currently stable, exhibited skin lesions similar to his wife who traveled to Saudi Arabia.

Pakistan reported its first mpox case of 2025 in Karachi, marking the city's first confirmed instance of the virus. The patient, a 28-year-old resident of Shah Latif Town, tested positive ...

Tecovirimat failed to reduce clade II mpox lesions, pain or viral clearance among participants in a study of the antiviral ...